Cargando…
Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387784/ https://www.ncbi.nlm.nih.gov/pubmed/34459132 http://dx.doi.org/10.1002/ctm2.398 |
_version_ | 1783742514211061760 |
---|---|
author | Zhang, Zheng Ji, Shunrong Hu, Qiangsheng Zhuo, Qifeng Liu, Wei Xu, Wenyan Liu, Wensheng Liu, Mengqi Ye, Zeng Fan, Guixiong Xu, Xiaowu Yu, Xianjun Qin, Yi |
author_facet | Zhang, Zheng Ji, Shunrong Hu, Qiangsheng Zhuo, Qifeng Liu, Wei Xu, Wenyan Liu, Wensheng Liu, Mengqi Ye, Zeng Fan, Guixiong Xu, Xiaowu Yu, Xianjun Qin, Yi |
author_sort | Zhang, Zheng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8387784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83877842021-08-31 Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer Zhang, Zheng Ji, Shunrong Hu, Qiangsheng Zhuo, Qifeng Liu, Wei Xu, Wenyan Liu, Wensheng Liu, Mengqi Ye, Zeng Fan, Guixiong Xu, Xiaowu Yu, Xianjun Qin, Yi Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-08-26 /pmc/articles/PMC8387784/ /pubmed/34459132 http://dx.doi.org/10.1002/ctm2.398 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Zhang, Zheng Ji, Shunrong Hu, Qiangsheng Zhuo, Qifeng Liu, Wei Xu, Wenyan Liu, Wensheng Liu, Mengqi Ye, Zeng Fan, Guixiong Xu, Xiaowu Yu, Xianjun Qin, Yi Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
title | Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
title_full | Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
title_fullStr | Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
title_full_unstemmed | Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
title_short | Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
title_sort | improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387784/ https://www.ncbi.nlm.nih.gov/pubmed/34459132 http://dx.doi.org/10.1002/ctm2.398 |
work_keys_str_mv | AT zhangzheng improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT jishunrong improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT huqiangsheng improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT zhuoqifeng improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT liuwei improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT xuwenyan improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT liuwensheng improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT liumengqi improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT yezeng improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT fanguixiong improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT xuxiaowu improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT yuxianjun improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer AT qinyi improvedtumorcontrolwithantiangiogenictherapyaftertreatmentwithgemcitabineandnabpaclitaxelinpancreaticcancer |